Formulation development for generics

Formulation development for generics
Product Description

At DiHeSys, we develop inks and polymers - individually for every single active ingredient. The corresponding formulation development takes place primarily in cooperation with the pharmaceutical industry. This approach allows us to offer our customers a steadily growing range of formulations tailored to their needs. The pharmaceutical industry thus secures access to the future market of personalized medicine with exciting projects and excellent margins.Contact us for more information and future cooperation.

Read more Show less

DiHeSys GmbH

  • Country/Region:
    Germany
  • On CPHI since:
    2019
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Manufacturer/Innovator
Other
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Anti-Allergens; Product Features; Product Performance; Reputation
  • Model
    2D / 3D formulation development
  • Supplied from
    Germany
More specifications Fewer specifications
Sales Markets
Show more Show less

DiHeSys GmbH

  • Country/Region:
    Germany
  • On CPHI since:
    2019
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Manufacturer/Innovator
Other
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile

More Products from DiHeSys GmbH (1)

  • FLEXDOSE® - 2D/3D printing technology

    Product FLEXDOSE® - 2D/3D printing technology

    FLEXDOSE® is the only pharmaceutical printer in the world that uses 2D printing in formulation manufacturing. In addition, FLEXDOSE® offers 3D printing options in the same housing. FLEXDOSE® is patented, CE certified, GMP compliant and has containment options to handle HPAPIs. We are already successfully w...